Alveolar Bone Loss
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
1
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Geistlich PharmaConventional protocol
VericelTissue Repair Cells
Clinical Trials (2)
Total enrollment: 37 patients across 2 trials
Interest of Bone Substitute Material in Immediate Complete Denture
Start: Oct 2013Est. completion: Mar 201837 patients
Phase 2/3Unknown
Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy
Start: Jun 2008Est. completion: May 2012
Phase 1/2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space